Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 7/2017

13.04.2017 | Head and Neck

Radioguided occult lesion localization for locally recurrent thyroid carcinoma

verfasst von: Mehmet Ali Gulcelik, Niyazi Karaman, Lutfi Dogan, Ilgın Sahiner, Gokhan Giray Akgul, Yavuz Selim Kahraman, Gulin Ucmak Vural

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to present our experiences with patients operated on for the recurrence of papillary thyroid cancer with the combined use of preoperative ultrasonographic mapping and radioguided occult lesion localization (ROLL). Twenty patients who had already undergone total thyroidectomy and central/lateral neck dissection for papillary thyroid carcinoma were reoperated on due to locoregional metastasis. The patients with proven recurrences and high Tg wash-out levels in cytopathologic aspirates were operated on. For each patient, numbers of marked and non-marked lesions, and the metastatic and total numbers of marked/non-marked and non-mentioned lesions in the maps were recorded. Thirty-four of 40 (85%) lesions removed with ROLL were found to be malignant. In addition to the marked lesions during mapping, 60 additional lesions had been defined as suspicious. Fifty-six of these lesions were found at exact anatomic sites and localizations described and removed. Of 56 lesions, 36 (64%) were found to be metastatic. During postoperative follow-up, chylous leak with spontaneous regression in 7 days and seroma occurred in one patient. Radioguided occult lesion localization and preoperative mapping contribute to the safety and comfort of patients in planned reoperations on lateral and central neck regions.
Literatur
1.
Zurück zum Zitat Mazzaferri EL, Kloos RT (2001) Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447–1463CrossRefPubMed Mazzaferri EL, Kloos RT (2001) Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447–1463CrossRefPubMed
2.
Zurück zum Zitat Coburn M, Teates D, Wanebo HJ (1994) Recurrent thyroid cancer: role of surgery versus radioactive iodine (131I). Ann Surg 6:587–595CrossRef Coburn M, Teates D, Wanebo HJ (1994) Recurrent thyroid cancer: role of surgery versus radioactive iodine (131I). Ann Surg 6:587–595CrossRef
3.
Zurück zum Zitat Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428CrossRefPubMed Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428CrossRefPubMed
4.
Zurück zum Zitat Chow SM, Law SC, Mendenhall WM, Au SK, Yau S, Yuen KT, Law CC, Lau WH (2002) Follicular thyroid carcinoma: prognostic factors and the role of radioiodine. Cancer 95:488–498CrossRefPubMed Chow SM, Law SC, Mendenhall WM, Au SK, Yau S, Yuen KT, Law CC, Lau WH (2002) Follicular thyroid carcinoma: prognostic factors and the role of radioiodine. Cancer 95:488–498CrossRefPubMed
6.
Zurück zum Zitat Bin Yousef HM, Alzahrani AS, Al Sobhi SS (2004) Preoperative neck ultrasonographic mapping for recurrent/persistent papillary thyroid cancer. World J Surg 28:1110–1114CrossRef Bin Yousef HM, Alzahrani AS, Al Sobhi SS (2004) Preoperative neck ultrasonographic mapping for recurrent/persistent papillary thyroid cancer. World J Surg 28:1110–1114CrossRef
7.
Zurück zum Zitat Alzahrani AS, Raef H, Sultan A, Al Sobhi S, Ingemansson S, Ahmed M, Al Mahfouz A (2002) Impact of cervical lymph node dissection on serum TG and the course of disease in TG-positive, radioactive iodine whole body scan-negative recurrent/persistent papillary thyroid cancer. J Endocrinol Invest 25:526–531CrossRefPubMed Alzahrani AS, Raef H, Sultan A, Al Sobhi S, Ingemansson S, Ahmed M, Al Mahfouz A (2002) Impact of cervical lymph node dissection on serum TG and the course of disease in TG-positive, radioactive iodine whole body scan-negative recurrent/persistent papillary thyroid cancer. J Endocrinol Invest 25:526–531CrossRefPubMed
8.
Zurück zum Zitat Maxon HR III, Englaro EE, Thomas SR, Hertzberg VS, Hinnefeld JD, Chen LS, Smith H, Cummings D, Aden MD (1992) Radioiodine-131 therapy for well-differentiated thyroid cancer—a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med 33:1132–1136PubMed Maxon HR III, Englaro EE, Thomas SR, Hertzberg VS, Hinnefeld JD, Chen LS, Smith H, Cummings D, Aden MD (1992) Radioiodine-131 therapy for well-differentiated thyroid cancer—a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med 33:1132–1136PubMed
9.
Zurück zum Zitat Grebe SK, Hay ID (1996) Thyroid cancer nodal metastases. The biologic significance and therapeutic considerations. Surg Oncol Clin N Am 5:43–63PubMed Grebe SK, Hay ID (1996) Thyroid cancer nodal metastases. The biologic significance and therapeutic considerations. Surg Oncol Clin N Am 5:43–63PubMed
10.
Zurück zum Zitat Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, Mciver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM (2009) Revised American Thyroid Association Management Guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214CrossRefPubMed Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, Mciver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM (2009) Revised American Thyroid Association Management Guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214CrossRefPubMed
11.
Zurück zum Zitat Kim MK, Mandel SH, Baloch Z, Livolsiv A, Langer JE, Didonato L, Fish S, Weber RS (2004) Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 130:1214–1216CrossRefPubMed Kim MK, Mandel SH, Baloch Z, Livolsiv A, Langer JE, Didonato L, Fish S, Weber RS (2004) Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 130:1214–1216CrossRefPubMed
12.
Zurück zum Zitat Salvatore M, Ruffini V, Reale F (2003) Radio-guided surgery for lymph node recurrences of differentiated thyroid cancer. World J Surg 27:770–775CrossRef Salvatore M, Ruffini V, Reale F (2003) Radio-guided surgery for lymph node recurrences of differentiated thyroid cancer. World J Surg 27:770–775CrossRef
13.
Zurück zum Zitat Gulec SA, Eckert M, Woltering EA (2002) Gamma probe-guided lymph node dissection (gamma picking) in differentiated thyroid carcinoma. Clin Nucl Med 27:859–861CrossRefPubMed Gulec SA, Eckert M, Woltering EA (2002) Gamma probe-guided lymph node dissection (gamma picking) in differentiated thyroid carcinoma. Clin Nucl Med 27:859–861CrossRefPubMed
14.
Zurück zum Zitat Agrawal A, Hall NC, Ringel MD, Povoski SP, Martin EW Jr (2008) Combined use of perioperative TSH stimulated (18) F-FDG PET/CT imaging and gamma probe radioguided surgery to localize and verify resection of iodine scan-negative recurrent thyroid carcinoma. Laryngoscope 118:2190–2194CrossRefPubMed Agrawal A, Hall NC, Ringel MD, Povoski SP, Martin EW Jr (2008) Combined use of perioperative TSH stimulated (18) F-FDG PET/CT imaging and gamma probe radioguided surgery to localize and verify resection of iodine scan-negative recurrent thyroid carcinoma. Laryngoscope 118:2190–2194CrossRefPubMed
15.
Zurück zum Zitat Rubello D, Salvatori M, Casara D, Piotto A, Toniato A, Gross MD, Al-Nahhas A, Muzzio PC, Pelizzo MR (2007) 99 mTc-sestamibi radio-guided surgery of loco-regional 131Iodine-negative recurrent thyroid cancer. Eur J Surg Oncol 33:902–906CrossRefPubMed Rubello D, Salvatori M, Casara D, Piotto A, Toniato A, Gross MD, Al-Nahhas A, Muzzio PC, Pelizzo MR (2007) 99 mTc-sestamibi radio-guided surgery of loco-regional 131Iodine-negative recurrent thyroid cancer. Eur J Surg Oncol 33:902–906CrossRefPubMed
16.
Zurück zum Zitat Tukenmez M, Erbil Y, Barbaros U, Dural C, Salmaslioglu A, Aksoy D, Mudun A, Ozarmağan S (2007) Radio-guided nonpalpable metastatic lymph node localization in patients with recurrent thyroid cancer. J Surg Oncol 96:534–538CrossRefPubMed Tukenmez M, Erbil Y, Barbaros U, Dural C, Salmaslioglu A, Aksoy D, Mudun A, Ozarmağan S (2007) Radio-guided nonpalpable metastatic lymph node localization in patients with recurrent thyroid cancer. J Surg Oncol 96:534–538CrossRefPubMed
17.
Zurück zum Zitat Priven I, Schwartz A, Yeh H (2003) Ultrasonographic localization and marking of a small recurrent thyroid papillary carcinoma. Thyroid 13:663CrossRefPubMed Priven I, Schwartz A, Yeh H (2003) Ultrasonographic localization and marking of a small recurrent thyroid papillary carcinoma. Thyroid 13:663CrossRefPubMed
18.
Zurück zum Zitat Kuna SK, Bracic I, Tesic V, Kuna K, Herceg GH, Dodig D (2006) Ultrasonographic differentiation of benign from malignant neck lymphadenopathy in thyroid cancer. J Ultrasound Med 25:1531–1537CrossRefPubMed Kuna SK, Bracic I, Tesic V, Kuna K, Herceg GH, Dodig D (2006) Ultrasonographic differentiation of benign from malignant neck lymphadenopathy in thyroid cancer. J Ultrasound Med 25:1531–1537CrossRefPubMed
19.
Zurück zum Zitat Ilgan S, Oztürk E, Yildiz R, Emer O, Ayan A, Görgülü S, Alagöz E, Deveci S, Ozgüven MA, Tufan T (2010) Combination of preoperative ultrasonographic mapping and radioguided occult lesion localization in patients with locally recurrent/persistent papillary thyroid carcinoma: a practical method for central compartment reoperations. Clin Nucl Med 35:847–852CrossRefPubMed Ilgan S, Oztürk E, Yildiz R, Emer O, Ayan A, Görgülü S, Alagöz E, Deveci S, Ozgüven MA, Tufan T (2010) Combination of preoperative ultrasonographic mapping and radioguided occult lesion localization in patients with locally recurrent/persistent papillary thyroid carcinoma: a practical method for central compartment reoperations. Clin Nucl Med 35:847–852CrossRefPubMed
20.
Zurück zum Zitat Martino A, Monaco L, Golia R, Miletto P, Capasso P, Lombardi C, De Chiara G, Iannace C, Basagni C, Caracciolo F (2010) A new radioguided procedure for localization and surgical treatment of neck node metastasis of papillary thyroid cancer. J Endocrinol Invest 33:339–342CrossRefPubMed Martino A, Monaco L, Golia R, Miletto P, Capasso P, Lombardi C, De Chiara G, Iannace C, Basagni C, Caracciolo F (2010) A new radioguided procedure for localization and surgical treatment of neck node metastasis of papillary thyroid cancer. J Endocrinol Invest 33:339–342CrossRefPubMed
21.
Zurück zum Zitat Jung YS, Kim SK, Park I, Ryu J, Kim SW, Lee CY, Lee J (2014) Surgical targeting of recurrent thyroid cancer using a novel mixture of 99m-technetium macroaggregated albumin and indocyanine green. Surg Innov 21:622–629CrossRefPubMed Jung YS, Kim SK, Park I, Ryu J, Kim SW, Lee CY, Lee J (2014) Surgical targeting of recurrent thyroid cancer using a novel mixture of 99m-technetium macroaggregated albumin and indocyanine green. Surg Innov 21:622–629CrossRefPubMed
22.
Zurück zum Zitat Borsò E, Grosso M, Boni G, Manca G, Bianchi P, Puccini M, Arganini M, Cabria M, Piccardo A, Arlandini A, Orlandini C, Mariani G (2013) Radioguided occult lesion localization of cervical recurrences from differentiated thyroid cancer: technical feasibility and clinical results. J Nucl Med Mol Imaging 57:401–411 Borsò E, Grosso M, Boni G, Manca G, Bianchi P, Puccini M, Arganini M, Cabria M, Piccardo A, Arlandini A, Orlandini C, Mariani G (2013) Radioguided occult lesion localization of cervical recurrences from differentiated thyroid cancer: technical feasibility and clinical results. J Nucl Med Mol Imaging 57:401–411
Metadaten
Titel
Radioguided occult lesion localization for locally recurrent thyroid carcinoma
verfasst von
Mehmet Ali Gulcelik
Niyazi Karaman
Lutfi Dogan
Ilgın Sahiner
Gokhan Giray Akgul
Yavuz Selim Kahraman
Gulin Ucmak Vural
Publikationsdatum
13.04.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 7/2017
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-017-4563-2

Weitere Artikel der Ausgabe 7/2017

European Archives of Oto-Rhino-Laryngology 7/2017 Zur Ausgabe

Nur selten Nachblutungen nach Abszesstonsillektomie

03.05.2024 Tonsillektomie Nachrichten

In einer Metaanalyse von 18 Studien war die Rate von Nachblutungen nach einer Abszesstonsillektomie mit weniger als 7% recht niedrig. Nur rund 2% der Behandelten mussten nachoperiert werden. Die Therapie scheint damit recht sicher zu sein.

Rezidivierender Peritonsillarabszess nach Oralsex

02.05.2024 Peritonsillarabszess Kasuistik

Die erotischen Dimensionen von Peritonsillarabszessen scheinen eng begrenzt zu sein. Das heißt aber nicht, solche Abszesse und Erotik hätten nichts miteinander gemein, wie ein Fallbericht verdeutlicht.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.